These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1370049)

  • 1. Quantification of Moraxella bovis haemagglutinating adhesins with monoclonal antibodies.
    Gil-Turnes C; Aleixo JA
    Lett Appl Microbiol; 1991 Aug; 13(2):55-7. PubMed ID: 1370049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic characterization of Moraxella bovis, Moraxella bovoculi and Moraxella ovis strains with potential use in vaccines.
    Kowalski AP; Maboni G; Gressler LT; Espíndola JP; Balzan C; Tasca C; Guizzo JA; Conceição FR; Frandoloso R; de Vargas AC
    Vet Microbiol; 2017 Oct; 210():56-63. PubMed ID: 29103697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled field trial to assess efficacy of a Moraxella bovis pilin-cytotoxin-Moraxella bovoculi cytotoxin subunit vaccine to prevent naturally occurring infectious bovine keratoconjunctivitis.
    Angelos JA; Gohary KG; Ball LM; Hess JF
    Am J Vet Res; 2012 Oct; 73(10):1670-5. PubMed ID: 23013196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Moraxella bovis antibodies in infectious bovine keratoconjunctivitis by a passive hemagglutination test.
    Arora AK; Killinger AH; Myers WL
    Am J Vet Res; 1976 Dec; 37(12):1489-92. PubMed ID: 999074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation and quantitation of pilus antigens of Moraxella bovis by ELISA.
    Lepper AW; Hermans LR
    Aust Vet J; 1986 Dec; 63(12):401-5. PubMed ID: 2879528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Moraxella bovis by using a monoclonal antibody to a lipopolysaccharide epitope.
    Wannemuehler Y; Johansen K; Rosenbusch R
    J Clin Microbiol; 1989 Dec; 27(12):2881-3. PubMed ID: 2480364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity and immunogenicity of piliated and nonpiliated phases of Moraxella bovis in calves.
    Jayappa HG; Lehr C
    Am J Vet Res; 1986 Oct; 47(10):2217-21. PubMed ID: 2877604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental production of infectious bovine keratoconjunctivitis.
    Aikman JG; Allan EM; Selman IE
    Vet Rec; 1985 Sep; 117(10):234-9. PubMed ID: 4095875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moraxella bovis hemagglutinins: effect of carbohydrates, heating and erythrocytes.
    Gil-Turnes C; Ribeiro GA
    Can J Comp Med; 1985 Jan; 49(1):112-4. PubMed ID: 3986674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An attempt to induce clinical infectious keratoconjunctivitis in calves with naturally occurring Moraxella bovis infection.
    Barber DM; Jones GE
    Vet Rec; 1988 Feb; 122(9):210. PubMed ID: 3381465
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis pilin-Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Bonifacio RG; Ball LM; Hess JF
    Vet Microbiol; 2007 Dec; 125(3-4):274-83. PubMed ID: 17656049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virulence genes in Moraxella spp. isolates from infectious bovine keratoconjunctivitis cases.
    Sosa V; Umpierrez A; Acquistapace S; Zunino P
    J Infect Dev Ctries; 2015 Sep; 9(9):1028-32. PubMed ID: 26409746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimentally induced infectious bovine keratoconjunctivitis: resistance of vaccinated cattle to homologous and heterologous strains of Moraxella bovis.
    Pugh GW; Hughes DE; Schulz VD; Graham CK
    Am J Vet Res; 1976 Jan; 37(1):57-60. PubMed ID: 1247198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the antimicrobial susceptibility profiles of Moraxella bovis, M. bovoculi and M. ovis.
    Maboni G; Gressler LT; Espindola JP; Schwab M; Tasca C; Potter L; de Vargas AC
    Braz J Microbiol; 2015 Jun; 46(2):545-9. PubMed ID: 26273272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic analysis of fimbrial proteins from Moraxella bovis.
    Moore LJ; Rutter JM
    J Clin Microbiol; 1987 Nov; 25(11):2063-70. PubMed ID: 2891723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of Moraxella spp. strains recovered from infectious bovine keratoconjunctivitis cases in Uruguay.
    Sosa V; Zunino P
    J Infect Dev Ctries; 2013 Nov; 7(11):819-24. PubMed ID: 24240039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of two commercial infectious bovine keratoconjunctivitis vaccines.
    Smith PC; Blankenship T; Hoover TR; Powe T; Wright JC
    Am J Vet Res; 1990 Jul; 51(7):1147-50. PubMed ID: 2389894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against infectious bovine keratoconjunctivitis: protective efficacy and antibody response induced by pili of homologous and heterologous strains of Moraxella bovis.
    Lepper AW
    Aust Vet J; 1988 Oct; 65(10):310-6. PubMed ID: 2904257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying Concepts of Causal Inference to Infectious Bovine Keratoconjunctivitis.
    O'Connor AM
    Vet Clin North Am Food Anim Pract; 2021 Jul; 37(2):267-278. PubMed ID: 34049658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine infectious keratoconjunctivitis: serological aspects of Moraxella bovis infection.
    Pugh GW; Hughes DE; McDonald TJ
    Can J Comp Med; 1971 Apr; 35(2):161-6. PubMed ID: 4253466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.